Insightful Earnings Call Recap: National Vision Holdings Inc. (EYE) Q4 2024 Description: National Vision Holdings Inc (NASDAQ:EYE) Q4 2024 Earnings Conference Call was held on February 26, 2025, at 8:00 AM ET. The conference call included key company officials such as Tamara Gonzalez – VP of Investor Relations, Reade Fahs
Unpacking the Numbers: A Recap of Saipem’s Q4 2024 Earnings Call Description: Saipem SpA (OTCPK:SAPMF) recently held its Q4 2024 Earnings Conference Call on February 26, 2025, at 4:30 AM ET. The call featured key company executives such as Chief Executive Officer Alessandro Puliti and Chief Financial Officer Paolo Calcagnini.
Revolutionizing Military and Government Strategies with Nexalin Technology Nexalin Welcomes General Wesley Clark to Advisory Board HOUSTON, TX, Feb. 26, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, is proud to announce a strategic partnership with General
Breaking Ground: Revelation Biosciences Administers First Dose in PRIME Phase 1b Clinical Trial for Gemini in CKD Patients Description SAN DIEGO–(BUSINESS WIRE)—- Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced dosing of the first
Hot and Fresh: A Recap of Domino’s Pizza Enterprises Limited’s Q4 2024 Earnings Call Description Domino’s Pizza Enterprises Limited (OTCPK:DPZUF) recently held their Q4 2024 Results Conference Call on February 24, 2025, at 7:00 PM ET. The call featured key figures such as Greg Lemenchick, Vice President of Investor Relations,
Breaking News: Cal-Maine Foods Inc. Strikes Deal with Founder’s Family! RIDGELAND, Miss.–(BUSINESS WIRE)– Cal-Maine Foods, Inc. (NASDAQ: CALM) (“Cal-Maine Foods” or the “Company”) today announced that it has entered into an agreement with members of the family of its founder Fred R. Adams, Jr., relating to the potential diversification of
Unleashing the Scoop: A Recap of Maple Leaf Foods Inc.’s Q4 2024 Earnings Call Description: Maple Leaf Foods Inc. (OTCPK: MLFNF) held its Q4 2024 Earnings Conference Call on February 25, 2025, at 8:00 AM ET. The call featured key company representatives, including Janet Craig – Investor Relations, Curtis Frank
Breaking News: Hammer Group Unveils Bold Restructuring Plan and Fintech Expansion! Description: New Initiatives Include the Launch of the HammerPay Remittance Platform and the Upcoming HammerPay Global Payments Service for Seamless Cross-Border Settlements Sarasota, Florida–(Newsfile Corp. – February 25, 2025) – Hammer Technologies Holdings Corp. (OTC: HMMR) (“Hammer Group”) is
Unlocking the Potential: Why Wall Street Experts are Buzzing About ADMA Biologics (ADMA) – Should You Invest? Description Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or
Unlocking the Potential: A Deep Dive into ARIS Water Solutions’ Q4 Performance and Wall Street Estimates for Key Metrics Description: Besides Wall Street’s top-and-bottom-line estimates for Aris Water Solutions (ARIS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared
Unlock the Power of Data with Data443’s Latest Launch: Introducing ClassiForAI – The Ultimate Solution for AI Classification! About Data443 Risk Mitigation, Inc. Data443 Risk Mitigation, Inc. (OTCPK: ATDS), also known as Data443, is a leading AI data security and privacy software company that specializes in providing solutions for “All
Unleash Your Power as a PCRX Investor: Join the Fight Against Securities Fraud with The Schall Law Firm Investors Beware: Class Action Lawsuit Against Pacira BioSciences, Inc. LOS ANGELES, Feb. 25, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action
Breaking Barriers: Femasys’ FemBloc Permanent Birth Control Clinical Trials Yield Positive Safety and Efficacy Results – A Peer-Reviewed Publication Description: Positive data from prospective, multi-center trials confirmed compelling effectiveness and five-year safety with high satisfaction from both patients and practitioners. ATLANTA, Feb. 25, 2025 (GLOBE NEWSWIRE) — Femasys Inc., (Nasdaq:
Breaking News: Finnovate Acquisition Corp. Delays Shareholder Meeting to March 17, 2025 at 10:00 AM Eastern Time! Boston, MA, Feb. 25, 2025 (GLOBE NEWSWIRE) — Finnovate Acquisition Corp. (“Finnovate”) (OTC: “FNVUF”, “FNVTF”, “FNVWF”) announced today that its upcoming extraordinary general meeting of shareholders (the “Special Meeting”) to approve its proposed
Breaking Ground: Jacobs Takes on Construction Manager Role for Fermilab’s DUNE Project Description: Complex infrastructure project will support facilities for the Deep Underground Neutrino Experiment at U.S. Department of Energy’s Fermilab’s Illinois site. DALLAS, Feb. 25, 2025 /PRNewswire/ — Jacobs (NYSE: J) was named the Construction Manager as Advisor (CMa)
Breaking News: Kiniksa Pharmaceuticals Unveils Exciting New Drug for Recurrent Pericarditis and Shares Corporate Strategy Update! Description: Kiniksa plans to initiate a Phase 2/3 clinical trial of KPL-387 in recurrent pericarditis in mid-2025. KPL-387 Phase 1 single ascending dose data support potential monthly dosing. Kiniksa continues to focus development on
Get notified about market movers
